<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095832</url>
  </required_header>
  <id_info>
    <org_study_id>1908-051-1055</org_study_id>
    <nct_id>NCT04095832</nct_id>
  </id_info>
  <brief_title>The Effect of Epidural Anesthesia on the Optic Nerve Sheath Diameter in Preeclampsia</brief_title>
  <acronym>ONSD</acronym>
  <official_title>The Effect of Epidural Anesthesia on the Optic Nerve Sheath Diameter in Preeclampsia: A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the effect of epidural anesthesia on the optic nerve sheath
      diameter in parturients with preeclampsia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective observational study will be performed in parturients, either with or without
      preeclampsia, who scheduled to undergo elective cesarean delivery under epidural anesthesia.
      Epidural anesthesia will be done according to the standard technique. Optic nerve sheath
      diameter (ONSD) will be measured before and after the epidural injection of anesthetic
      solutions using ultrasonography. The investigators will assess whether epidural anesthesia
      has effect on optic nerve sheath diameter of pregnant women, and the investigators will also
      compare ONSD between healthy parturients and parturients with preeclampsia. The investigators
      will evaluate the relationship between ONSD and disease severity of preeclampsia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optic nerve sheath diameter (ONSD) after epidural anesthesia</measure>
    <time_frame>3 minutes after the completion of epidural injection of the anesthetic solutions</time_frame>
    <description>measured by transocular ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Optic nerve sheath diameter (ONSD)</measure>
    <time_frame>before epidural anesthesia, 10, 20 minutes after the completion of epidural injection of the anesthetic solutions, 10 minutes after delivery of fetus, at the end of surgery.</time_frame>
    <description>measured by transocular ultrasonography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>on delivery day</time_frame>
    <description>blood pressure in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proteinuria</measure>
    <time_frame>during the admission period</time_frame>
    <description>The presence of Proteinuria during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epigastric pain</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of epigastric pain during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of Headache during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual disturbances</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of Visual disturbances during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oliguria</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of Oliguria during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eclampsia</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of seizure during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intracranial hemorrhage</measure>
    <time_frame>during the admission period</time_frame>
    <description>The occurrence of intracranial hemorrhage during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>during the admission period</time_frame>
    <description>Serum creatinine concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum albumin</measure>
    <time_frame>during the admission period</time_frame>
    <description>Serum albumin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet count</measure>
    <time_frame>during the admission period</time_frame>
    <description>Platelet count measured during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AST</measure>
    <time_frame>during the admission period</time_frame>
    <description>AST measured during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar Score of fetus</measure>
    <time_frame>at 1 min, 5 min</time_frame>
    <description>Apgar Score of delivered fetus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical arterial pH</measure>
    <time_frame>immediately after delivery</time_frame>
    <description>pH in mmol/L, Umbilical arterial blood gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ALT</measure>
    <time_frame>during the admission period</time_frame>
    <description>ALT measured during the admission period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical arterial base excess</measure>
    <time_frame>immediately after delivery</time_frame>
    <description>base excess in mmol/L, Umbilical arterial blood gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical arterial PO2</measure>
    <time_frame>immediately after delivery</time_frame>
    <description>PO2 in mmHg, Umbilical arterial blood gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical arterial PCO2</measure>
    <time_frame>immediately after delivery</time_frame>
    <description>PCO2 in mmHg, Umbilical arterial blood gas analysis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>Parturients with preeclampsia</arm_group_label>
    <description>Parturients who were diagnosed with preeclampsia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy parturients</arm_group_label>
    <description>Healthy full-term parturients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural anesthesia</intervention_name>
    <description>Epidural anesthesia using standardized technique</description>
    <arm_group_label>Healthy parturients</arm_group_label>
    <arm_group_label>Parturients with preeclampsia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We plans to include 11 preeclamptic patients and 11 healthy pregnant women.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo planned cesarean section under epidural anesthesia if
             they have a singleton pregnancy, complicated by severe preeclampsia.

        Severe preeclampsia was defined using the American College of Obstetricians and
        Gynecologist Task Force on Hypertension in Pregnancy recommendations

          -  Controls will be healthy pregnant women at term (&gt;37 weeks), with a singleton
             pregnancy, no signs or symptoms of preeclampsia and no intrauterine fetal growth
             restriction, who are planned to undergo elective cesarean delivery under epidural
             anesthesia

        Exclusion Criteria:

          -  Contraindication to epidural anesthesia

          -  Morbid cardiovascular disease

          -  Cerebrovascular disease

          -  Known fetal anomaly

          -  Any signs of onset of labor

          -  Body weight &lt; 40 kg or body weight &gt; 100 kg

          -  Height &lt; 140cm or height &gt; 190cm

          -  eye disease

          -  infection or trauma near the eyes

          -  abnormality of intracranial pressure due to Intracranial pathology
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sun-Kyung Park</last_name>
    <phone>0220722499</phone>
    <email>mayskpark@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun-Kyung Park, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Brzan Simenc G, Ambrozic J, Prokselj K, Tul N, Cvijic M, Mirkovic T, Lucovnik M. Ocular ultrasonography for diagnosing increased intracranial pressure in patients with severe preeclampsia. Int J Obstet Anesth. 2018 Nov;36:49-55. doi: 10.1016/j.ijoa.2018.06.005. Epub 2018 Jul 4.</citation>
    <PMID>30057149</PMID>
  </reference>
  <reference>
    <citation>Ortner CM, Krishnamoorthy V, Neethling E, Flint M, Swanevelder JL, Lombard C, Fawcus S, Dyer RA. Point-of-Care Ultrasound Abnormalities in Late-Onset Severe Preeclampsia: Prevalence and Association With Serum Albumin and Brain Natriuretic Peptide. Anesth Analg. 2019 Jun;128(6):1208-1216. doi: 10.1213/ANE.0000000000003759.</citation>
    <PMID>31094790</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>September 16, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

